Boston – Pfizer CEO Says Clinton Plan To Curb Drug Prices Would Hurt Consumers

    7

    FILE - Ian Read, chief executive officer of Pfizer, listens to a reporter's question at a news conference in New York November 5, 2013. ReutersBoston – Pfizer Inc’s chief executive on Thursday said recent proposals by Democratic presidential candidate Hillary Clinton to curb “unjustified” U.S. drug prices would dampen investment in innovative new drugs and ultimately hurt consumers.

    Join our WhatsApp group

    Subscribe to our Daily Roundup Email


    “(They) would be very negative for innovation,” Ian Read said in webcast from the annual Wells Fargo healthcare conference in Boston. He said Clinton’s proposals, if ever approved, would ultimately lead to a one-payer government system of price controls on prescription medicines.

    Critics of the pharmaceutical industry have long argued that drugmakers unfairly raise prices at will, making their products increasingly less accessible to patients. Drugmakers counter that it can cost $1 billion dollars or more to develop the typical drug and say they need to be reimbursed for the costs and risk-taking.

    Read said he did not believe price controls like those seen in Europe would occur in the United States.

    “A lot depends on the composition of the Senate and House,” he added, referring to whether Republicans continue to dominate at least one branch of Congress and can be a counterweight to a potential Clinton White House.

    Clinton last week said that if elected to the White House she would create an oversight panel to protect U.S. consumers from large price hikes on long-available, lifesaving drugs and to import alternative treatments if necessary, adding to her pledges to rein in overall drug prices.

    She said the oversight panel would be able to levy fines and impose penalties on manufacturers when there has been an unjustified “outlier” price increase on a long-available or generic drug, meaning an especially high increase.


    Listen to the VINnews podcast on:

    iTunes | Spotify | Google Podcasts | Stitcher | Podbean | Amazon

    Follow VINnews for Breaking News Updates


    Connect with VINnews

    Join our WhatsApp group


    7 Comments
    Most Voted
    Newest Oldest
    Inline Feedbacks
    View all comments
    PaulinSaudi
    PaulinSaudi
    7 years ago

    How may I say this politely? I think this man is a liar.

    bennyt
    bennyt
    7 years ago

    Big pharma has been ripping off Americans for decades. The same exact drugs are available in European countries for a fraction of what Americans pay. Their CEOs belong behind bars.

    Butterfly
    Butterfly
    7 years ago

    The American drug companies are making $$ hand over fist. Some drugs that work in both Europe and Canada are not allowed in the USA!! Dare we ask why? It is not the competition either!!

    RebelSheep
    RebelSheep
    7 years ago

    Wow, Big Pharma doesn’t want drug prices lowered. I’m shocked.

    ayoyo
    ayoyo
    7 years ago

    Sorry but reimbursement in my book means recovering money lost, not making huge prophets on drugs that can be purchased in foreign countries for a lot less than here. Perhaps they don’t want to give money to the politicians to continue robbing the consumers.